Related Experiment Video

Updated: Jun 16, 2026

Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells
09:37

Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells

Published on: August 25, 2021

[Targeted therapy: toward a clean and effective war against cancer]

V Castronovo1, D Waltregny, O Detry

  • 1Laboratoire de Recherche sur les Metastases (GIGA-Cancer), Université de Liège, Liège, Belgique.

Revue Medicale De Liege
|January 21, 2010
PubMed

Insights

Developing targeted anticancer drugs requires identifying tumor-specific biomarkers accessible to therapies. Innovative proteomic technologies can discover these crucial accessible biomarkers for improved cancer treatment strategies.

Area of Science:

  • Oncology
  • Proteomics
  • Biomarker Discovery

Context:

  • Targeted drug delivery aims to enhance anticancer efficacy and reduce side effects.
  • Tumor-associated biomarkers are key targets for selective cancer therapies.
  • Current biomarker discovery methods often fail to assess tissue accessibility for systemic drugs.

Purpose:

  • To highlight the criteria for selecting ideal therapeutic biomarkers: accessibility, expression level, and specificity.
  • To emphasize the limitations of traditional biomarker discovery in assessing in vivo accessibility.
  • To introduce innovative proteomic technologies as a solution for identifying accessible biomarkers.

Summary:

  • Effective anticancer drug development relies on targeting tumor biomarkers accessible to systemic therapies.
  • Biomarker eligibility requires accessibility, sufficient expression, and minimal normal tissue presence.
  • Proteomic technologies offer novel methods to identify these accessible biomarkers, crucial for targeted therapy development.

Impact:

  • Facilitates the discovery of novel, accessible biomarkers for next-generation targeted cancer therapies.
  • Enables the development of more selective and effective anticancer drugs.
  • Accelerates the clinical translation of targeted therapies by addressing a critical biomarker discovery gap.

More Related Videos

Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down08:59

Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down

Published on: December 11, 2017

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...